J MICHAEL REDMOND
CIK 1200166 · President · last filed 2024-09-20
J MICHAEL REDMOND is a President who has filed 12 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for OGEN, was dated Sep 20, 2024.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
12
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OGEN | President | — | $0.62 | — | $0 | 2 | 2024-09-20 |
| BIOJECT MEDICAL TECHNOLOGIES INC (BJCT) Delisted | Sr. VP Bus Dev. | 225,828 | — | — | $0 | 4 | 2007-05-01 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-20 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2024-07-16 | — | Grant (A) | — | $0 | |
| 2024-01-02 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2024-01-02 | — | Grant (A) | — | $0 | |
| 2023-01-13 | — | Grant (A) | — | $0 | |
| 2022-09-15 | — | Gift (G) | −1,500,000 | -$244.9K | |
| 2022-06-08 | — | Grant (A) | — | $0 | |
| 2021-03-01 | — | Mixed | — | $0 | |
| 2007-05-01 | BIOJECT MEDICAL TECHNOLOGIES INC (BJCT) Delisted | Mixed | +130,807 | -$43.2K | EDGAR |
| 2007-03-12 | BIOJECT MEDICAL TECHNOLOGIES INC (BJCT) Delisted | Mixed | +7,500 | -$3.2K | EDGAR |